Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 

Statistics by Country for Carnitine palmitoyl transferase II deficiency, lethal neonatal form

Prevalance of Carnitine palmitoyl transferase II deficiency, lethal neonatal form:

the lethal neonatal form of carnitine palitoyl transferase II deficiency has been reported in 10 families, Genetics Home Reference website

About extrapolations of prevalence and incidence statistics for Carnitine palmitoyl transferase II deficiency, lethal neonatal form:

WARNING! EXTRAPOLATED STATISTICS ONLY! Not based on data sources from individual countries. These statistics are calculated extrapolations of various prevalence or incidence rates against the populations of a particular country or region. The statistics used for prevalence/incidence of Carnitine palmitoyl transferase II deficiency, lethal neonatal form are typically based on US, UK, Canadian or Australian prevalence or incidence statistics, which are then extrapolated using only the population of the other country. This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences across the various countries and regions for which the extrapolated Carnitine palmitoyl transferase II deficiency, lethal neonatal form statistics below refer to. The extrapolation does not use data sources or statistics about any country other than its population. As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication) as to the actual prevalence or incidence of Carnitine palmitoyl transferase II deficiency, lethal neonatal form in that region. These statistics are presented only in the hope that they may be interesting to some people.

About prevalence and incidence statistics in general for Carnitine palmitoyl transferase II deficiency, lethal neonatal form:

The word 'prevalence' of Carnitine palmitoyl transferase II deficiency, lethal neonatal form usually means the estimated population of people who are managing Carnitine palmitoyl transferase II deficiency, lethal neonatal form at any given time (i.e. people with Carnitine palmitoyl transferase II deficiency, lethal neonatal form). The term 'incidence' of Carnitine palmitoyl transferase II deficiency, lethal neonatal form means the annual diagnosis rate, or the number of new cases of Carnitine palmitoyl transferase II deficiency, lethal neonatal form diagnosed each year (i.e. getting Carnitine palmitoyl transferase II deficiency, lethal neonatal form). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise